Bharat Biotech has started the Phase 1 of human clinical trial of Covaxin, India’s first indigenous COVID-19 vaccine. The trial began on July 15.
Bharat Biotech said, “India’s First Indigenous COVID 19 Vaccine, COVAXIN, initiated Phase-1 clinical trials across the country on 15th July 2020.”
“We are proud to announce the start of Phase 1 human clinical trial of Covaxin on July 15th, 2020. This is a randomised, double-blind, placebo-controlled clinical trial in 375 volunteers in India,” it tweeted a post.